Skip to main content
. Author manuscript; available in PMC: 2013 Dec 20.
Published in final edited form as: Aliment Pharmacol Ther. 2013 Jan 24;37(5):10.1111/apt.12218. doi: 10.1111/apt.12218

Table 2.

Patient Characteristics for Stool Study

Cases
N = 19
Controls
N = 35
CUC 17 25
Crohn’s disease 2 10
% Male 63 63
Median age, years (range) 60 (45–72) 60 (45–77)
Median IBD duration, years (range) 30 (2–50) 14 (0–45) 1
Extensive (%)2 17 (89) 19 (54)3
IBD Activity4
  Inactive (%) 8 (42) 12 (38)
  Mild (%) 9 (45) 11 (34)
  Moderate (%) 1 (5) 3 (9)
  Severe (%) 1 (5) 6 (19)
PSC (%) 4 (21) 5 (16)
1

p=0.0008

2

Inflammation proximal to splenic flexure

3

p=0.01

4

Disease activity could not be confirmed for 3 control patients

CUC, chronic ulcerative colitis; IBD, inflammatory bowel disease; PSC, primary sclerosing cholangitis.

Cases = IBD with colorectal neoplasia, Controls = IBD without neoplasia

HHS Vulnerability Disclosure